A plan to bring down drug prices could threaten America’s technology boom
Forty years ago, Kendall Square in Cambridge, Massachusetts, was full of deserted warehouses and dying low-tech factories. Today, it is arguably the center of the global biotech industry. During my 30 years in MIT’s Technology Licensing Office, I witnessed this transformation firsthand, and I know it was no accident. Much of it was the direct…